DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC AND UV METHOD FOR PROTEASE INHIBITOR: A REVIEW

被引：0
作者：
Patil, Akshay B. [1 ]
Gurumukhi, Vishal C. [1 ]
Chalikwar, Shailesh S. [1 ]
Chaudhari, Dhanshri A. [1 ]
机构：
[1] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut Qual Assurance, Shirpur, India
来源：
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2019年 / 6卷 / 04期
关键词：
RP-HPLC; UV-spectrophotometry; Validation; Stability indicating; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; QUANTITATIVE-DETERMINATION; ANTIRETROVIRAL AGENTS; NELFINAVIR MESYLATE; ATAZANAVIR; RITONAVIR; INDINAVIR; SAQUINAVIR; DRUG;
D O I：
10.5281/zenodo.2652047
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A technique for the analysis of various duds using RP-HPLC and UV is an essential tool in chromatography. The HPLC method is able to separate, detect and selectively quantify the various drugs. After the method development using HPLC validation is done for the performance and reproducibility and repeatability and accuracy. Also, it will help to find out the limitations of the method and influence of factors to quantify the drug. Further, according to ICH guidelines, the established method processed with stability indicating evaluation to find out the robustness of the method. It includes forced degradation with acidic, basic, neutral condition, oxidation, photolytic degradation also done. In this review, we presented a protease inhibitor class drug and its quantification using HPLC and UV.
引用
收藏
页码：8381 / 8400
页数：20
相关论文
共 46 条
  • [1] [Anonymous], 2017, STABILITY INDICATING, V6, P576, DOI [10.20959/wjpps20172-8486, DOI 10.20959/WJPPS20172-8486]
  • [2] Behera A., 2011, Chronicles of Young Scientists, V2, P161, DOI [10.4103/2229-5186.90894, DOI 10.4103/2229-5186.90894]
  • [3] Clinical pharmacology, efficacy and safety of atazanavir: a review
    Bentue-Ferrer, Daniele
    Arvieux, Cedric
    Tribut, Olivier
    Ruffault, Annick
    Bellissant, Eric
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (11) : 1455 - 1468
  • [4] Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography
    Burger, DM
    de Graaff, M
    Wuis, EW
    Koopmans, PP
    Hekster, YA
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1997, 703 (1-2): : 235 - 241
  • [5] Atazanavir for the treatment of human immunodeficiency virus infection
    Busti, AJ
    Hall, RG
    Margolis, DM
    [J]. PHARMACOTHERAPY, 2004, 24 (12): : 1732 - 1747
  • [6] Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography
    Cateau, E
    Tournier, N
    Dupuis, A
    Le Moal, G
    Venisse, N
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) : 791 - 795
  • [7] Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection
    Cattaneo, Dario
    Maggiolo, Franco
    Ripamonti, Diego
    Perico, Norberto
    [J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2008, 46 (06) : 485 - 489
  • [8] Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles
    Chakraborty, Subhashis
    Shukla, Dali
    Vuddanda, Parameswara Rao
    Mishra, Brahmeshwar
    Singh, Sanjay
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 81 (02) : 563 - 569
  • [9] Chandra P., 2017, J GLOBAL TRENDS PHAR, V8, P4198
  • [10] Periodontists' perspective of HIV manifestations
    Chatterjee, Soham
    Shetty, Neetha J.
    Nayak, Sangeeta U.
    [J]. HIV & AIDS REVIEW, 2018, 17 (04): : 229 - 235
12345